Tools
Tools
Weeratunga, Praveen, Bancone, Germana, Ochodo, Eleanor A, Pant, Smriti, Thapa, Jeevan and Chaplin, Martha (2021) 'Glucose‐6‐phosphate dehydrogenase deficiency near‐patient tests for tafenoquine or primaquine use with Plasmodium vivax malaria (Protocol)'. Cochrane Database of Systematic Reviews, Vol 2021, Issue 1, CD013861.
|
Text
Weeratunga_et_al-2021-Cochrane_Database_of_Systematic_Reviews.pdf - Published Version Download (249kB) | Preview |
Abstract
Objectives
This is a protocol for a Cochrane Review (diagnostic). The objectives are as follows:
To assess the diagnostic accuracy of near‐patient tests for G6PD deficiency in people undergoing treatment or prophylaxis with primaquine or tafenoquine for malaria; or in people at risk of or susceptible to malaria.
Secondary objectives
To investigate sources of heterogeneity, namely the following.
Age: adults versus children
Sex: male versus female
Reported prevalence of G6PD (high versus low)
Malaria endemicity (endemic versus non‐endemic)
Geographic location (continent of residence; that is, Africa, Asia, or other continent)
Reference standard used (adjusted male median, median G6PD, laboratory standard)
Type of blood used (venous versus capillary)
To compare the accuracy of each type of test.
| Item Type: | Article |
|---|---|
| Subjects: | QV Pharmacology > Anti-Inflammatory Agents. Anti-Infective Agents. Antineoplastic Agents > QV 256 Antimalarials QX Parasitology > Protozoa > QX 135 Plasmodia WC Communicable Diseases > Tropical and Parasitic Diseases > WC 750 Malaria |
| Faculty: Department: | Clinical Sciences & International Health > Clinical Sciences Department |
| Digital Object Identifer (DOI): | https://doi.org/10.1002/14651858.CD013861 |
| Depositing User: | Christianne Esparza |
| Date Deposited: | 02 Feb 2021 12:06 |
| Last Modified: | 26 Jan 2022 02:02 |
| URI: | https://archive.lstmed.ac.uk/id/eprint/16832 |
Statistics
Actions (login required)
 |
Edit Item |